- page

Scroll to explore

Scroll back top

Domain Therapeutics Discloses DT-9046 as a Groundbreaking Oral Drug Candidate for Inflammatory Disea...

indice d’égalité femmes-hommes 2025

27 February 2025

Domain Therapeutics to present and participate at major global healthcare conferences, March to June...

4 February 2025

Labiotech – World Cancer Day: trends in cancer therapeutics to look forward to in 2025

28 January 2025

Pharmaphorum – Pharma holds it breath for ’25 as the sun shines on JP Morgan conference

Happy New Year from all of us at Domain Therapeutics !

29 October 2024

Labiotech – GPCR therapies: Eight promising biotechs hacking the cell signaling pathway

23 October 2024

Prix Galien USA: Domain Therapeutics Nominated for the Prestigious Best Startup Award

Domain Therapeutics strengthens its intellectual property for its series of Treg depleting anti-CCR...

Oncologypipeline – CCR8 expectations